Table 1.
Sample Demographic and Clinical Characteristics
| |
Full sample |
BD-I |
BD-II |
MDD |
MDD+ |
|---|---|---|---|---|---|
| |
598 |
39 |
84 |
422 |
53 |
| Mean (SD) | |||||
| Age, years | 15.13 (1.5) | 15.64 (1.3)d | 15.45 (1.4)d | 15.08 (1.5) | 14.62 (1.8)a,b |
| Length of stay (days) | 7.81 (6.1) | 10.08 (5.9)c | 7.86 (3.3) | 7.24 (5.2)a,d | 10.53 (12.3)c |
| n (%) | |||||
|---|---|---|---|---|---|
| Female | 427 (71) | 30 (77) | 64 (76) | 296 (70) | 37 (70) |
| Race | |||||
| White | 271 (45) | 13 (33) | 39 (47) | 199 (47) | 20 (38) |
| Black | 91 (15) | 5 (13) | 18 (22) | 62 (15) | 6 (11) |
| Asian | 60 (10) | 4 (10) | 9 (11) | 38 (9) | 9 (17) |
| Other/multiracial | 104 (17) | 11 (28) | 13 (16) | 70 (17) | 10 (19) |
| Declined | 82 (14) | 6 (15) | 5 (6) | 53 (13) | 8 (15) |
| Hospitalization status | |||||
| Hospitalized more than once | 96 (16) | 17 (44)b,c,d | 18 (21)a | 50 (12)a | 11 (21)a |
| Readmitted in 30 days | 26 (4) | 6 (15)c | 5 (6) | 11 (3)a | 4 (7) |
| Comorbid disorders | |||||
| Anxiety disorder | 94 (16) | 2 (5) | 4 (5)c | 78 (19)b | 10 (19) |
| Substance use disorder | 34 (6) | 1 (3) | 4 (5) | 26 (6) | 3 (6) |
| Disruptive behavioral disorder | 10 (2) | 1 (3) | 2 (2) | 5 (1) | 2 (4) |
a
Different from BD-I, p <0 .05.
b
Different from BD-II, p < 0.05.
c
Different from MDD, p < 0.05.
d
Different from MDD+ psychosis/mixed symptoms, p < 0.05.
BD, bipolar disorder; DBD, disruptive behavioral disorder (i.e., attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder); MDD, major depressive disorder; MDD+, major depressive disorder with psychosis and/or mixed features; SD, standard deviation.